Cargando…

Pre-clinical evaluation of CYP 2D6 dependent drug–drug interactions between primaquine and SSRI/SNRI antidepressants

BACKGROUND: The liver-stage anti-malarial activity of primaquine and other 8-aminoquinoline molecules has been linked to bio-activation through CYP 2D6 metabolism. Factors such as CYP 2D6 poor metabolizer status and/or co-administration of drugs that inhibit/interact with CYP 2D6 could alter the pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Xiannu, Potter, Brittney, Luong, Thu-lan, Nelson, Jennifer, Vuong, Chau, Potter, Corttney, Xie, Lisa, Zhang, Jing, Zhang, Ping, Sousa, Jason, Li, Qigui, Pybus, Brandon S., Kreishman-Deitrick, Mara, Hickman, Mark, Smith, Philip L., Paris, Robert, Reichard, Gregory, Marcsisin, Sean R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869338/ https://www.ncbi.nlm.nih.gov/pubmed/27188854 http://dx.doi.org/10.1186/s12936-016-1329-z

Ejemplares similares

Risks of using SSRI / SNRI antidepressants during pregnancy and lactation
por: Dubovicky, Michal, et al.
Publicado: (2017)

The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
por: Pybus, Brandon S, et al.
Publicado: (2013)

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden
por: Zoega, Helga, et al.
Publicado: (2015)

Do Triptan Antimigraine Medications Interact with SSRI/SNRI Antidepressants? What Does Your Decision Support System Say?
por: Kogut, Stephen J.
Publicado: (2011)

Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
por: Pasi, Patrick, et al.
Publicado: (2023)

CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine
por: Pybus, Brandon S, et al.
Publicado: (2012)

Discontinuation Rates and Health Care Costs in Adult Patients Starting Generic Versus Brand SSRI or SNRI Antidepressants in Commercial Health Plans
por: Kautzner, Adam, et al.
Publicado: (2011)

Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials
por: Koechlin, Helen, et al.
Publicado: (2021)

Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data
por: Aakjær, Mia, et al.
Publicado: (2021)

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study
por: Rosenberg, Ted, et al.
Publicado: (2017)

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients
por: Yoshimura, Reiji, et al.
Publicado: (2012)

Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan
por: Cheng, Yuan-Lung, et al.
Publicado: (2015)

Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
por: Spring, Michele D, et al.
Publicado: (2020)

Long-Term Prophylaxis and Pharmacokinetic Evaluation of Intramuscular Nano- and Microparticle Decoquinate in Mice Infected with P. berghei Sporozoites
por: Li, Qigui, et al.
Publicado: (2017)

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
por: Spring, Michele D, et al.
Publicado: (2019)

Comparative Assessment of Adherence Measures and Resource Use in SSRI/SNRI-Treated Patients with Depression Using Second-Generation Antipsychotics or L-Methylfolate as Adjunctive Therapy
por: Wade, Rolin L., et al.
Publicado: (2014)

Enantioselective metabolism of primaquine by human CYP2D6
por: Fasinu, Pius S, et al.
Publicado: (2014)

Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections
por: Li, Qigui, et al.
Publicado: (2014)

Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei
por: Milner, Erin E., et al.
Publicado: (2016)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
por: Courtet, Philippe
Publicado: (2010)

Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes
por: Fasinu, Pius S., et al.
Publicado: (2016)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

Identification of SSRI-evoked antidepressant sensory signals by decoding vagus nerve activity
por: West, Christine L., et al.
Publicado: (2021)

Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
por: Chairat, Kalayanee, et al.
Publicado: (2018)

In Response
por: Grogl, Max, et al.
Publicado: (2014)

CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever
por: Marcsisin, Sean R, et al.
Publicado: (2013)

Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments
por: Gupta, Ramesh K, et al.
Publicado: (2006)

Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants
por: Herzallah, Mohammad M., et al.
Publicado: (2013)

Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
por: Ben-Sheetrit, Joseph, et al.
Publicado: (2023)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malaria
por: Caridha, Diana, et al.
Publicado: (2019)

Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
por: Foletto, Vitória Segabinazzi, et al.
Publicado: (2022)

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
por: Wong, Win Lee Edwin, et al.
Publicado: (2023)

Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain
por: Orrico-Sanchez, Alejandro, et al.
Publicado: (2023)

The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2015)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2016)

Evaluation of the effect of long-term use of antidepressants in the SSRI group on bone density with dental volumetric tomography
por: Agacayak, Kamil Serkan, et al.
Publicado: (2019)

Mapping the physiological and molecular markers of stress and SSRI antidepressant treatment in S100a10 corticostriatal neurons
por: Sargin, Derya, et al.
Publicado: (2019)

TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli
por: Ou, Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6t8gtmfb5l3qsmvdiaq6tmqdh